Array
(
[id] => 18255901
[patent_doc_number] => 20230082940
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-03-16
[patent_title] => DEVICES AND METHODS FOR DETECTION OF SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2
[patent_app_type] => utility
[patent_app_number] => 17/796239
[patent_app_country] => US
[patent_app_date] => 2021-05-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12991
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 125
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17796239
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/796239 | DEVICES AND METHODS FOR DETECTION OF SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2 | May 16, 2021 | Pending |
Array
(
[id] => 17831485
[patent_doc_number] => 20220268789
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-08-25
[patent_title] => MONOCLONAL ANTIBODY AGAINST AMYLOID BETA, AND METHOD FOR MEASURING AMYLOID BETA-RELATED PEPTIDE USING SAID ANTIBODY
[patent_app_type] => utility
[patent_app_number] => 17/623010
[patent_app_country] => US
[patent_app_date] => 2020-04-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12765
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17623010
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/623010 | MONOCLONAL ANTIBODY AGAINST AMYLOID BETA, AND METHOD FOR MEASURING AMYLOID BETA-RELATED PEPTIDE USING SAID ANTIBODY | Apr 6, 2020 | Pending |
Array
(
[id] => 17596956
[patent_doc_number] => 20220146530
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-05-12
[patent_title] => A COMBINATION OF BIOMARKERS FOR DIAGNOSING OF AGE-RELATED MACULAR DEGENERATION AND USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/436571
[patent_app_country] => US
[patent_app_date] => 2020-03-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8145
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 32
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17436571
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/436571 | A COMBINATION OF BIOMARKERS FOR DIAGNOSING OF AGE-RELATED MACULAR DEGENERATION AND USE THEREOF | Mar 5, 2020 | Pending |